Catheter Precision (VTAK) Invested Capital (2020 - 2026)

Catheter Precision (VTAK) has reported Invested Capital for 7 consecutive years, with $334.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Invested Capital rose 3333.72% year-over-year to $334.8 million in Q2 2026; TTM through Jun 2026 was $334.8 million, a 3333.72% increase from a year earlier, with the FY2025 full-year figure at $9.1 million, down 32.26% from the prior year.
• Invested Capital was $334.8 million for Q2 2026 at Catheter Precision, up from $27.0 million in the prior quarter.
• Over five years, Invested Capital peaked at $334.8 million in Q2 2026 and troughed at $9.1 million in Q4 2025.
• A 5-year average of $40.4 million and a median of $14.3 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital tumbled 63.2% in 2025 and soared 3333.72% in 2026, its largest moves.
• Over 5 years, Invested Capital stood at $9.3 million in 2022, then surged by 130.85% to $21.4 million in 2023, then slumped by 37.16% to $13.4 million in 2024, then slumped by 32.26% to $9.1 million in 2025, then soared by 3578.6% to $334.8 million in 2026.
• The last three Invested Capital figures came in at $334.8 million (Q2 2026), $27.0 million (Q1 2026), and $9.1 million (Q4 2025), per Business Quant data.